Literature DB >> 11487366

Malaria diagnosis and treatment under the strategy of the integrated management of childhood illness (IMCI): relevance of laboratory support from the rapid immunochromatographic tests of ICT Malaria P.f/P.v and OptiMal.

D S Tarimo1, J N Minjas, I C Bygbjerg.   

Abstract

The algorithm developed for the integrated management of childhood illness (IMCI) provides guidelines for the treatment of paediatric malaria. In areas where malaria is endemic, for example, the IMCI strategy may indicate that children who present with fever, a recent history of fever and/or pallor should receive antimalarial chemotherapy. In many holo-endemic areas, it is unclear whether laboratory tests to confirm that such signs are the result of malaria would be very relevant or useful. Children from a holo-endemic region of Tanzania were therefore checked for malarial parasites by microscopy and by using two rapid immunochromatographic tests (RIT) for the diagnosis of malaria (ICT Malaria P.f/P.v and OptiMal. At the time they were tested, each of these children had been targeted for antimalarial treatment (following the IMCI strategy) because of fever and/or pallor. Only 70% of the 395 children classified to receive antimalarial drugs by the IMCI algorithm had malarial parasitaemias (68.4% had Plasmodium falciparum trophozoites, 1.3% only P. falciparum gametocytes, 0.3% P. ovale and 0.3% P. malariae). As indicators of P. falciparum trophozoites in the peripheral blood, fever had a sensitivity of 93.0% and a specificity of 15.5% whereas pallor had a sensitivity of 72.2% and a specificity of 50.8%. The RIT both had very high corresponding sensitivities (of 100.0% for the ICT and 94.0% for OptiMal) but the specificity of the ICT (74.0%) was significantly lower than that for OptiMal (100.0%). Fever and pallor were significantly associated with the P. falciparum asexual parasitaemias that equalled or exceeded the threshold intensity (2000/microl) that has the optimum sensitivity and specificity for the definition of a malarial episode. Diagnostic likelihood ratios (DLR) showed that a positive result in the OptiMal test (DLR = infinity) was a better indication of malaria than a positive result in the ICT (DLR = 3.85). In fact, OptiMal had diagnostic reliability (0.93) which approached that of an ideal test and, since it only detects live parasites, OptiMal is superior to the ICT in monitoring therapeutic responses. Although the RIT may seem attractive for use in primary health facilities because relatively inexperienced staff can perform them, the high cost of these tests is prohibitive. In holo-endemic areas, use of RIT or microscopical examination of bloodsmears may only be relevant when malaria needs to be excluded as a cause of illness (e.g. prior to treatment with toxic or expensive drugs, or during malaria epidemics). Wherever the effective drugs for the first-line treatment of malaria are cheap (e.g. chloroquine and Fansidar), treatment based on clinical diagnosis alone should prove cost-saving in health facilities without microscopy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487366     DOI: 10.1080/13648590120068971

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  21 in total

1.  Shifting from presumptive to test-based management of malaria - technical basis and implications for malaria control in Ghana.

Authors:  F Baiden; K Malm; C Bart-Plange; A Hodgson; D Chandramohan; J Webster; S Owusu-Agyei
Journal:  Ghana Med J       Date:  2014-06

Review 2.  Reduction in the proportion of fevers associated with Plasmodium falciparum parasitaemia in Africa: a systematic review.

Authors:  Valérie D'Acremont; Christian Lengeler; Blaise Genton
Journal:  Malar J       Date:  2010-08-22       Impact factor: 2.979

3.  Prescribing practice for malaria following introduction of artemether-lumefantrine in an urban area with declining endemicity in West Africa.

Authors:  Joseph U Okebe; Brigitte Walther; Kawsu Bojang; Silaba Drammeh; David Schellenberg; David J Conway; Michael Walther
Journal:  Malar J       Date:  2010-06-24       Impact factor: 2.979

Review 4.  Malaria diagnosis: a brief review.

Authors:  Noppadon Tangpukdee; Chatnapa Duangdee; Polrat Wilairatana; Srivicha Krudsood
Journal:  Korean J Parasitol       Date:  2009-05-26       Impact factor: 1.341

Review 5.  Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries.

Authors:  Katharine Abba; Jonathan J Deeks; Piero Olliaro; Cho-Min Naing; Sally M Jackson; Yemisi Takwoingi; Sarah Donegan; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

Review 6.  Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries.

Authors:  Katharine Abba; Amanda J Kirkham; Piero L Olliaro; Jonathan J Deeks; Sarah Donegan; Paul Garner; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2014-12-18

7.  Accuracy of malaria rapid diagnosis test Optimal-IT(®) in Kinshasa, the Democratic Republic of Congo.

Authors:  Hypolite Mavoko Muhindo; Gillon Ilombe; Ruth Meya; Patrick M Mitashi; Albert Kutekemeni; Didier Gasigwa; Pascal Lutumba; Jean-Pierre Van Geertruyden
Journal:  Malar J       Date:  2012-07-06       Impact factor: 2.979

8.  Comparative evaluation of two rapid field tests for malaria diagnosis: Partec Rapid Malaria Test® and Binax Now® Malaria Rapid Diagnostic Test.

Authors:  Bernard Nkrumah; Samuel Ek Acquah; Lukeman Ibrahim; Juergen May; Norbert Brattig; Egbert Tannich; Samuel Blay Nguah; Yaw Adu-Sarkodie; Frank Huenger
Journal:  BMC Infect Dis       Date:  2011-05-23       Impact factor: 3.090

9.  Operational accuracy and comparative persistent antigenicity of HRP2 rapid diagnostic tests for Plasmodium falciparum malaria in a hyperendemic region of Uganda.

Authors:  Daniel J Kyabayinze; James K Tibenderana; George W Odong; John B Rwakimari; Helen Counihan
Journal:  Malar J       Date:  2008-10-29       Impact factor: 2.979

10.  Performance of the OptiMAL dipstick in the diagnosis of malaria infection in pregnancy.

Authors:  Harry Tagbor; Jane Bruce; Edmund Browne; Brian Greenwood; Daniel Chandramohan
Journal:  Ther Clin Risk Manag       Date:  2008-06       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.